Clinical Trial Update: ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of Kadcyla (ado-trastuzumab emtansine) for HER2-positive breast cancer is ongoing but currently not recruiting, sponsored by Dana-Farber Cancer In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Kadcyla (ado-trastuzumab emtansine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING